Cancer Targeting Systems

Cancer Targeting Systems (CTS) is developing a new non-viral, gene therapy-based approach for the treatment of cancer. Nanoparticles are administered systemically, distribute throughout the patient’s body and address metastatic tumours. Gene expression of a therapeutic payload is cancer cell specific, and triggers local activation of the immune system, leading to cancer cell destruction.